Synopsys (SNPS) Valuation After Q2 Beat Ansys Integration Progress And New Samsung AI Chip Design Alliance
Synopsys (SNPS) stock is back in focus after a busy week that combined Q2 earnings, higher full year guidance, and fresh AI centric design collaborations with Samsung Foundry on advanced semiconductor nodes.
See our latest analysis for Synopsys.
Despite a 3.50% one-day share price gain to US$492.29 after the earnings and Samsung Foundry announcements, Synopsys is still only modestly higher year to date with a 2.47% share price return. The 5-year total shareholder return of 94.90% reflects much stronger longer term compounding.
If the AI chip design story has your attention, it can be useful to see what else is moving and compare Synopsys with 47 AI infrastructure stocks
Synopsys now trades around US$492 with a 1 year total return of 5.61%, a 5 year total return near 7x, and a small discount to analyst targets. This raises the question of whether there is still a buying opportunity here or if future growth is already priced in.
Most Popular Narrative: 9% Undervalued
Synopsys last closed at $492.29, while the most widely followed narrative pegs fair value around $539.69, built on detailed revenue, margin, and earnings assumptions.
The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.
Curious what sits behind that fair value gap? The narrative leans on faster earnings growth, richer margins, and a premium future earnings multiple that hinges on those forecasts holding up.
Result: Fair Value of $539.69 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story can change quickly if China related weakness persists, or if Ansys integration and cost cuts fail to deliver the expected margins and earnings power.
Find out about the key risks to this Synopsys narrative.
Another View: Rich Multiples Raise the Bar
The narrative fair value suggests Synopsys trades around a 9% discount, yet the current P/E of 121.9x is far higher than the US Software industry at 29.3x, the peer average at 42.5x, and even the fair ratio estimate of 51.9x. This points to meaningful valuation risk if growth expectations slip.
If you want to see how this pricing gap stacks up in a simple, numbers first way, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of enthusiasm and concern in this story, it makes sense to move quickly, stress test the numbers yourself, and see how they stack up against the 1 key reward and 3 important warning signs
Looking for more investment ideas?
If you stop with just one stock, you risk missing other clear opportunities, so keep going and let the data point you toward your next move.
- Target dependable cash generators by scanning 47 high quality undervalued stocks that combine quality fundamentals with pricing that may still be attractive.
- Prioritize resilience by reviewing 62 resilient stocks with low risk scores that carry lower overall risk scores while still offering meaningful exposure to the market.
- Spot under-the-radar opportunities by checking the screener containing 22 high quality undiscovered gems before the crowd catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Synopsys might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com